Goldman Sachs Alternatives Life Sciences

Funding rounds backed by Goldman Sachs Alternatives Life Sciences.

Export CSV
Funding disclosed in full
$189M
Median round
$94.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Sidewinder Therapeutics

Develops next-generation bispecific ADCs for cancer treatment

$137MSeries BBiotechUnited States
9 participantsAlexandria Real Estate EquitiesAstellas Venture ManagementDCVC BioFrazier Life SciencesGoldman Sachs Alternatives Life SciencesLongwood FundNovartis Venture FundOrbiMedSamsara BioCapital
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+BiotechUnited States
11 participantsAbbVie VenturesabrdnAlderline GroupAndreessen Horowitz (a16z)BVF Partners LPGalapagos NVGoldman Sachs Alternatives Life SciencesHillhouse InvestmentMarshall WaceOmega FundsT. Rowe Price Associates